Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVir Biotechnology, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$2.44 | $0.01 | -$1.05 |
| Q2 2024 | 3 | -$2.08 | $0.01 | -$0.89 |
| Q3 2024 | 2 | -$2.44 | $0.01 | -$1.05 |
| Q4 2024 | 6 | -$0.99 | -$0.68 | -$0.87 |
| Q1 2025 | 2 | -$0.91 | -$0.67 | -$0.79 |
| Q2 2025 | 1 | -$1.89 | $0.01 | -$0.82 |
| Q3 2025 | 1 | -$1.97 | $0.01 | -$0.85 |
| Q4 2025 | 1 | -$2.17 | $0.01 | -$0.93 |
Vir Biotechnology, Inc. Earnings Date And Information
Vir Biotechnology, Inc. last posted its earnings results on Thursday, October 31st, 2024. The company reported $-1.56 earnings per share for the quarter, missing analysts' consensus estimates of $-0.96 by $0.6. The company had revenue of 2.38 M for the quarter and had revenue of 86.18 M for the year. Vir Biotechnology, Inc. has generated $-5 earnings per share over the last year ($-4.59 diluted earnings per share) and currently has a price-to-earnings ratio of -1.85. Vir Biotechnology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Vir Biotechnology, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2024 | Q3 2024 | -$1.56 | $5.54 M | $2.38 M | ||
| 08/01/2024 | Q2 2024 | -$0.93 | -$1.02 | -0.09 | $7.53 M | $3.08 M |
| 05/03/2024 | Q1 2024 | -$0.48 | $56.38 M | |||
| 02/26/2024 | Q4 2023 | -$0.86 | $16.79 M | |||
| 11/03/2023 | Q3 2023 | -$1.22 | $8.71 M | $-4,098,000 | ||
| 08/04/2023 | Q2 2023 | -$1.45 | $22.39 M | $-12,722,000 | ||
| 05/08/2023 | Q1 2023 | -$1.06 | $46.71 M | |||
| 02/28/2023 | Q4 2022 | -$0.76 | $21.79 M | |||
| 11/03/2022 | Q3 2022 | -$0.21 | $1.32 | 1.53 | $114.22 M | $371.43 M |
| 08/09/2022 | Q2 2022 | -$0.17 | -$0.58 | -0.41 | $200.72 M | $-42,687,000 |
| 05/05/2022 | Q1 2022 | $3.78 | $3.93 | 0.15 | $1.23 B | |
| 02/28/2022 | Q4 2021 | $4.01 | $809.76 M | |||
| 11/04/2021 | Q3 2021 | $0.02 | $0.85 | 0.83 | $138.25 M | $102.71 M |
| 08/05/2021 | Q2 2021 | -$0.48 | $0.48 | 0.96 | $84.56 M | $173.99 M |
| 05/06/2021 | Q1 2021 | -$0.23 | -$1.32 | -1.09 | $605,000 | |
| 02/25/2021 | Q4 2020 | -$0.72 | -$0.83 | -0.11 | $301,000 | |
| 11/10/2020 | Q3 2020 | -$0.57 | -$0.67 | -0.1 | $11.01 M | $188,000 |
| 08/11/2020 | Q2 2020 | -$0.62 | -$0.27 | 0.35 | $3.90 M | $66.27 M |
| 05/12/2020 | Q1 2020 | -$0.48 | -$0.71 | -0.23 | $487,000 | |
| 03/26/2020 | Q4 2019 | -$0.69 | $371,000 |
Vir Biotechnology, Inc. Earnings: FAQ's
When is Vir Biotechnology, Inc.'s earnings date?
Vir Biotechnology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
How can I listen to Vir Biotechnology, Inc.'s earnings conference
call?
The conference call for Vir Biotechnology, Inc.'s latest earnings report can be listened to online.
How can I read Vir Biotechnology, Inc.'s conference call transcript?
The conference call transcript for Vir Biotechnology, Inc.'s latest earnings report can be read online.
How much revenue does Vir Biotechnology, Inc. generate each year?
Vir Biotechnology, Inc. (:VIR) has a recorded annual revenue of $86.18 M.
How much profit does Vir Biotechnology, Inc. generate each year?
Vir Biotechnology, Inc. (:VIR) has a recorded net income of $86.18 M. Vir Biotechnology, Inc. has generated $-4.59 earnings per share over the last four quarters.
What is Vir Biotechnology, Inc.'s price-to-earnings ratio?
Vir Biotechnology, Inc. (:VIR) has a price-to-earnings ratio of -1.85 and price/earnings-to-growth ratio is 0.19.